Characterizing differences between MSCs and TM cells: Toward autologous stem cell therapies for the glaucomatous trabecular meshwork

Keyphrases

• Trabecular Meshwork Cells 100%
• Trabecular Meshwork 100%
• Glaucomatous 100%
• Mesenchymal Stem Cells 100%
• Autologous Stem Cell Therapy 100%
• Quantitative PCR 28%
• Glaucoma 28%
• Contractility 28%
• Phagocytosis 28%
• Western Blotting 14%
• Myocilin 14%
• Regenerative Medicine 14%
• Protein Level 14%
• Flow Cytometry 14%
• Stem Cell Therapy 14%
• Intraocular Pressure 14%
• Cell Source 14%
• Glaucoma Patients 14%
• Therapeutic Potential 14%
• Characterization Techniques 14%
• Potential Therapeutics 14%
• Messenger 14%
• Medicine Application 14%
• Cellularity 14%
• Protein Markers 14%
• Autologous Cells 14%
• Causes of Blindness 14%
• Discriminating Factor 14%
• Aqueous Humor Outflow 14%
• Adipose-derived Mesenchymal Stem Cells (ADMSCs) 14%

Neuroscience

• Cell Therapy 100%
• Stem Cell 100%
• Trabecular Meshwork 100%
• Mesenchymal Stem Cell 100%
• Glaucoma 21%
• Reverse Transcription 14%
• Phagocytosis 14%
• Real-Time Polymerase Chain Reaction 14%
• Western Blot 7%
• Intraocular Pressure 7%
• Flow Cytometry 7%
• Dexamethasone 7%
• Adipose Tissue 7%
• Aqueous Humor Outflow 7%
• Myocilin 7%

Biochemistry, Genetics and Molecular Biology

• Stem Cell 100%
• Autologous Stem Cell Transplantation 100%
• Muscle Contractility 33%
• Quantitative Reverse Transcription Polymerase Chain Reaction 33%
• Phagocytosis 33%
• Western Blot 16%
• Stem Cell Transplantation 16%
• Intraocular Pressure 16%
• Flow Cytometry 16%
• Dexamethasone 16%
• Aqueous Humor Outflow 16%